- Cell Culture Dish Spotlights Exbumin for Use in Vaccine Manufacturing after Regulatory Filing and Approval
Thank you for your interest in the Cell Culture Dish article detailing Kara Quinn’s and Merck’s journey of successfully launching the globally game changing ERVEBO® Ebola vaccine.
If you want to view the online seminar, it can be accessed at the IPEC-Americas website.
It was exciting for InVitria to play a role in this journey. Our Exbumin™ recombinant human serum albumin remains the only rHSA available that the FDA and EMA have approved as an excipient.
Albumin has myriad uses across multiple biopharma and biotech applications, including cell & gene therapies, vaccine development & manufacture, medical devices & coatings, and final formulations & excipients. Exbumin is uniquely positioned to serve the needs of those looking for a regulatory approved rHSA that is animal-free, blood-free, and cGMP manufactured for inclusion in products and final formulations.
If you have other interests and applications requiring the performance, consistency, and risk mitigation advantages of an animal-, human-, and blood-free albumin, we’d be happy to further discuss your application. We have a range of blood-free rHSA products suited for many different processes and uses, from cell culturing to antioxidant stabilization to medical device coatings and everything in-between.